Warfarin Sodium
Product Images NDC 70934-588

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-588). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 588 30 Master Bottle Label Approval Rev A 02 20)

Label (70934 588 30 Master Bottle Label Approval   Rev A 02 20)
Warfarin Sodium Tablets USP 4 mg packaging label from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label indicates a box of 30 tablets with storage instructions and warnings including prescription-only status and bleeding risk. The label also shows multiple peel-off sections with product information and lot and expiration date placeholders.*
FDA Label Image

Chemical Structure (Warfarin 1)

Chemical Structure (Warfarin 1)
Chemical structure of Warfarin Sodium, showing the molecular arrangement including benzene rings, oxygen atoms, and a sodium ion (Na) within the compound's skeletal formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.